Artificial Intelligence
April 23–25, 2018
Boston, MA • United States

Marc Semigran, MD

  • CMO, Myokardia

Marc Semigran, MD, is Chief Medical Officer of Myokardia, a clinical stage biotechnology company targeting the treatment of cardiomyopathies based on a knowledge of the genetic basis for the abnormalities in myocardial function. Prior to joining Myokardia in late 2016, Dr. Semigran served as Medical Director of the Massachusetts General Hospital Cardiac Transplant Program and an Associate Professor of Medicine at Harvard Medical School, Boston, Massachusetts. He is a graduate of Harvard College and received his MD degree from the Harvard/Massachusetts Institute of Technology Health Sciences and Technology Program. He completed his internal medicine residency and cardiology fellowship training at Massachusetts General Hospital, Boston.

This speaker appears at this event: